Copyright 2016 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
In Reply The letters from Drs Dunnenberger and Khandekar and Dr Snyderman and colleagues speak of data that are “promising” and “being generated,” work “still in its developmental stages,” and “the inevitability of progress,” which reinforce our view that a gap looms between the hype surrounding personalized medicine and its potential for real-world success.
The letters also raise an eighth question: What exactly is personalized medicine? The term seems capable of expanding or contracting as needed. Articles with personalized medicine in the title are overwhelmingly about the use of genomic information.
Joyner MJ, Paneth N. Value of Personalized Medicine—Reply. JAMA. 2016;315(6):613-614. doi:10.1001/jama.2015.17142